Search Results 91-100 of 16143 for anti-TNF drugs

  1. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

  2. Drugs and Supplements that Start with I - Mayo Clinic

    Adalimumab (subcutaneous route). Idacio. Also known as. Adalimumab-aacf (subcutaneous route). Idamycin PFS. Also known as. Idarubicin (intravenous route).

  3. Mayo Clinic Q and A: Medications in use and being tested for treatment of COVID-19

    Researchers study many anti-inflammatory drugs to treat or prevent dysfunction of several organs and lung injury from infection-associated inflammation. Immune- ...

  4. Mayo Clinic Minute: What are NSAIDs?

    ... medications called NSAIDs. "That stands for nonsteroidal anti-inflammatory drugs," says Dr. Carrie Krieger, a clinical pharmacist at Mayo Clinic. Ibuprofen ...

  5. COVID-19 (coronavirus) drugs: Are there any that work?

    The corticosteroid dexamethasone is one type of anti-inflammatory drug being studied to treat or prevent organ dysfunction and lung injury from inflammation. A ...

  6. Antidepressants: Another weapon against chronic pain - Mayo Clinic

    Medications from other drug classes with distinct mechanisms of pain relief (such as anticonvulsants) may be used in combination with antidepressant class ...

  7. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MQC-20463208. Medical Professionals; The microbiome, fecal ...

  8. Asthma medications: Know your options - Mayo Clinic

    Inhaled corticosteroids. These anti-inflammatory drugs are the most effective and commonly used long-term control medications for asthma. They reduce swelling ...

  9. Cytotoxic Action of Novel Anti-Neoplastic Agents - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the cytotoxic action of novel anti-neoplastic agents.

  10. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    This study will evaluate the efficacy and safety of two adalimumab induction regimens in subjects with moderately to severely active Crohn's disease and ...